ARTICLE | Clinical News
Sofosbuvir/velpatasvir/voxilaprevir: Phase III data
October 31, 2016 7:00 AM UTC
Top-line data from the open-label, international Phase III POLARIS-2 trial in 941 patients with chronic HCV genotypes 1-6 infection who were not previously treated with a direct-acting antiviral (DAA)...